Houlihan Lokey Advises Bausch Health

Houlihan Lokey is pleased to announce that Bausch Receivables Funding LP, an Ontario limited partnership and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE:BHC, TSX:BHC), has entered into a $600 million committed, approximate five-year-term non-recourse receivables facility. Proceeds will be used for general corporate purposes. The financing transaction was signed on June 30, 2023.

Bausch Health Companies Inc. (Bausch) is a Canada-based global diversified pharmaceutical company whose mission is to improve people’s lives with its healthcare products. The company develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health through its controlling interest in Bausch + Lomb. With its leading durable brands, Bausch is delivering on its commitment to build an innovative company dedicated to advancing global health.

Houlihan Lokey served as the exclusive financial advisor and placement agent to Bausch Health Companies Inc.

RELATED: Healthcare, Capital Markets